Free Trial

Treace Medical Concepts (TMCI) News Today

$8.12
-0.06 (-0.73%)
(As of 07/12/2024 08:52 PM ET)
Treace Medical Concepts logo with Medical background
TimesSquare Capital Management LLC Decreases Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
TimesSquare Capital Management LLC lowered its position in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 20.9% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 1,384,129 shares of the company's stock after selling 364,991 s
Treace Medical Concepts logo with Medical background
Treace Medical Concepts (NASDAQ:TMCI) Shares Up 11.4%
Treace Medical Concepts (NASDAQ:TMCI) Stock Price Up 11.4%
Treace Medical Concepts logo with Medical background
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Short Interest Down 20.1% in June
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) was the recipient of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 4,057,300 shares, a decline of 20.1% from the May 31st total of 5,080,000 shares. Currently, 9.3% of the shares of the company are short sold. Based on an average trading volume of 1,252,300 shares, the days-to-cover ratio is currently 3.2 days.
Treace Medical Concepts logo with Medical background
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Hold" by Brokerages
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has earned a consensus rating of "Hold" from the seven brokerages that are currently covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a hold rating. The average 12-month price target among anal
Treace Medical Concepts logo with Medical background
Perceptive Advisors LLC Reduces Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Perceptive Advisors LLC cut its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 31.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,250,405 shares of the company's stock aft
Treace Medical Concepts, Inc. (NASDAQ:TMCI) CEO Buys $264,600.00 in Stock
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) CEO John T. Treace purchased 45,000 shares of Treace Medical Concepts stock in a transaction dated Tuesday, June 11th. The stock was bought at an average cost of $5.88 per share, with a total value of $264,600.00. Following the completion of the transaction, the chief executive officer now owns 6,388,095 shares in the company, valued at approximately $37,561,998.60. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link.
Norges Bank Invests $8.73 Million in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Norges Bank bought a new position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 684,278 shares of the company's stock, valued at approximately $8,725
Armistice Capital LLC Invests $36.41 Million in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Armistice Capital LLC bought a new position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,856,000 shares of the company's stock, valued at
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Director James T. Treace Purchases 25,000 Shares
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) Director James T. Treace purchased 25,000 shares of the business's stock in a transaction that occurred on Friday, May 31st. The shares were purchased at an average cost of $6.05 per share, with a total value of $151,250.00. Following the completion of the acquisition, the director now directly owns 1,139,441 shares of the company's stock, valued at $6,893,618.05. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Hold" by Brokerages
Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have received an average recommendation of "Hold" from the seven brokerages that are covering the firm, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation. The average 12-month
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Sees Large Growth in Short Interest
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 4,550,000 shares, a growth of 49.7% from the April 30th total of 3,040,000 shares. Based on an average daily trading volume, of 994,100 shares, the days-to-cover ratio is presently 4.6 days. Approximately 10.4% of the shares of the company are short sold.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Director Buys $253,500.00 in Stock
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) Director James T. Treace acquired 50,000 shares of the firm's stock in a transaction dated Tuesday, May 28th. The shares were purchased at an average price of $5.07 per share, with a total value of $253,500.00. Following the completion of the transaction, the director now owns 1,089,441 shares of the company's stock, valued at $5,523,465.87. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Director Richard W. Mott Buys 12,100 Shares
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) Director Richard W. Mott bought 12,100 shares of Treace Medical Concepts stock in a transaction that occurred on Wednesday, May 22nd. The shares were acquired at an average price of $4.99 per share, with a total value of $60,379.00. Following the acquisition, the director now directly owns 1,054,944 shares of the company's stock, valued at approximately $5,264,170.56. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Insider Buying: Treace Medical Concepts, Inc. (NASDAQ:TMCI) CEO Acquires 100,000 Shares of Stock
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) CEO John T. Treace acquired 100,000 shares of the business's stock in a transaction on Friday, May 17th. The shares were purchased at an average price of $5.56 per share, for a total transaction of $556,000.00. Following the purchase, the chief executive officer now directly owns 6,343,095 shares of the company's stock, valued at $35,267,608.20. The transaction was disclosed in a filing with the SEC, which is available through this link.
Unveiling 6 Analyst Insights On Treace Medical Concepts
Treace Medical Concepts (NASDAQ:TMCI) Cut to "Neutral" at UBS Group
UBS Group cut Treace Medical Concepts from a "buy" rating to a "neutral" rating and decreased their target price for the stock from $16.00 to $6.50 in a research note on Thursday.
Deepti Jain Buys 25,000 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) Stock
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) Director Deepti Jain bought 25,000 shares of the business's stock in a transaction dated Friday, May 10th. The stock was acquired at an average price of $4.50 per share, for a total transaction of $112,500.00. Following the purchase, the director now directly owns 31,235 shares in the company, valued at $140,557.50. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
TimesSquare Capital Management LLC Raises Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
TimesSquare Capital Management LLC boosted its position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 22.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,749,120 shares of the co
UBS Group Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $16.00
UBS Group reduced their price target on Treace Medical Concepts from $17.00 to $16.00 and set a "buy" rating for the company in a report on Wednesday.
Treace Medical Concepts (NASDAQ:TMCI) Releases Earnings Results, Meets Estimates
Treace Medical Concepts (NASDAQ:TMCI - Get Free Report) released its earnings results on Tuesday. The company reported ($0.30) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.30). Treace Medical Concepts had a negative net margin of 26.47% and a negative return on equity of 33.96%. The firm had revenue of $51.11 million during the quarter, compared to analyst estimates of $49.07 million. During the same quarter last year, the business earned ($0.23) EPS. The business's revenue was up 21.1% on a year-over-year basis.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the six analysts that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and five have issued a buy
Get Treace Medical Concepts News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.

Brace Yourself: Experts calling for Bitcoin to hit $100k (Ad)

For the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon.

Click here to get The Crypto Bull Run Millionaire Blueprint now.

TMCI Media Mentions By Week

TMCI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TMCI
News Sentiment

1.23

0.92

Average
Medical
News Sentiment

TMCI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TMCI Articles
This Week

3

2

TMCI Articles
Average Week

Get Treace Medical Concepts News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TMCI) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners